Cargando…

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers

Natural killer (NK) cells, a cytotoxic lymphocyte lineage, are able to kill tumor cells in vitro and in mouse models. However, whether these cells display an anti-tumor activity in cancer patients has not been demonstrated. Here we have addressed this issue in patients with several hematological can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzywinska, Ewelina, Allende-Vega, Nerea, Cornillon, Amelie, Vo, Dang-Nghiem, Cayrefourcq, Laure, Panabieres, Catherine, Vilches, Carlos, Déchanet-Merville, Julie, Hicheri, Yosr, Rossi, Jean-François, Cartron, Guillaume, Villalba, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634619/ https://www.ncbi.nlm.nih.gov/pubmed/26629531 http://dx.doi.org/10.1016/j.ebiom.2015.08.021

Ejemplares similares

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity
por: Krzywinska, Ewelina, et al.
Publicado: (2016)

Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
por: Sanchez-Martinez, Diego, et al.
Publicado: (2018)

Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function
por: Vo, Dang-Nghiem, et al.
Publicado: (2020)

The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism
por: Allende-Vega, Nerea, et al.
Publicado: (2015)

Human Leukemic Cells performing Oxidative Phosphorylation (OXPHOS) Generate an Antioxidant Response Independently of Reactive Oxygen species (ROS) Production
por: Khan, Abrar Ul Haq, et al.
Publicado: (2015)

Editorial: “Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives”
por: Kabelitz, Dieter, et al.
Publicado: (2015)

Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies
por: Gâtel, Pierre, et al.
Publicado: (2020)

NK Cells Acquire CCR5 and CXCR4 by Trogocytosis in People Living with HIV-1
por: Vo, Dang-Nghiem, et al.
Publicado: (2022)

γδ T Cell-Mediated Immunity to Cytomegalovirus Infection
por: Khairallah, Camille, et al.
Publicado: (2017)

Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation
por: Couzi, Lionel, et al.
Publicado: (2015)

Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status
por: Belkahla, Sana, et al.
Publicado: (2017)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
por: Villalba, Martin, et al.
Publicado: (2020)

Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications
por: Lawand, Myriam, et al.
Publicado: (2017)

NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells
por: Campos-Mora, Mauricio, et al.
Publicado: (2023)

Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells
por: Allende-Vega, Nerea, et al.
Publicado: (2019)

NK Cells in the Treatment of Hematological Malignancies
por: Gonzalez-Rodriguez, Ana P, et al.
Publicado: (2019)

Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma
por: Boyer, Magali, et al.
Publicado: (2020)

Circulating Tumor Cell Detection and Polyomavirus Status in Merkel Cell Carcinoma
por: Boyer, Magali, et al.
Publicado: (2020)

Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
por: Cayrefourcq, Laure, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
por: Balcik-Ercin, Pelin, et al.
Publicado: (2021)

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance
por: Garciaz, Sylvain, et al.
Publicado: (2021)

NK Cell-Based Immunotherapy for Hematological Malignancies
por: Sivori, Simona, et al.
Publicado: (2019)

Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020)

Natural Killer Cells Promote Early CD8 T Cell Responses against Cytomegalovirus
por: Robbins, Scott H, et al.
Publicado: (2007)

Natural Killer Cells Modulation in Hematological Malignancies
por: Baier, Céline, et al.
Publicado: (2013)

Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission
por: Dumas, Pierre‐Yves, et al.
Publicado: (2019)

Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30(+) Lymphoma
por: Tudesq, Jean-Jacques, et al.
Publicado: (2017)

Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma
por: Lehmann, Julia, et al.
Publicado: (2023)

Monitoring NK cell activity in patients with hematological malignancies
por: Viel, Sébastien, et al.
Publicado: (2013)

Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2016)

Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
por: Zhang, Ben-ning, et al.
Publicado: (1997)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells
por: Houh, Youn Kyung, et al.
Publicado: (2017)

What Fuels Natural Killers? Metabolism and NK Cell Responses
por: Gardiner, Clair M., et al.
Publicado: (2017)

Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
por: Murugan, Dhanashree, et al.
Publicado: (2022)

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
por: Brown, Bruce K., et al.
Publicado: (2012)

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL
por: Morello, Aurore, et al.
Publicado: (2013)

Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection
por: Howard, Jennifer, et al.
Publicado: (2018)

The metabolism of cells regulates their sensitivity to NK cells depending on p53 status
por: Belkahla, Sana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69jvf3dulsp301ufkfs6i9d0t7